Medical cannabis company IM Cannabis Corp. IMCC IMCC made its debut on the NASDAQ Capital Market on Monday becoming the first Israeli cannabis company to do so.
Shares experienced volatility on decent volume, closing the day up almost 5%. At the time of the writing of this article on Tuesday, shares were up by 8%.
In an email to Benzinga, IM Cannabis CEO Oren Shuster said he and his team are “extremely proud” to be the first Israeli medical cannabis operator to join the NASDAQ capital market “along with a select group of leading cannabis companies." He added:
“By joining NASDAQ, IMC provides American investors with access and a gateway to investments in the emerging European and Israeli cannabis markets where we have a strong presence and operations. Very few cannabis companies can boast having a decade-long experience in the medical cannabis space and we are leveraging this experience to further propel our international growth into additional high-potential markets."
Earlier this year, IM Cannabis entered the North American market through the acquisition of Canada-based Trichome Financial TFC and its adult-use cannabis operations.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.